JOHNSON & JOHNSON is 80.4x more valuable than TG THERAPEUTICS, INC. by market capitalization ($574.10 B vs $7.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TGTX | JNJ |
|---|---|---|
| Market cap | $7.14 B | $574.10 B |
| US-listed rank | #1140 | #20 |
| Revenue (latest FY) | $616.29M | $94.19B |
| Net income (latest FY) | $447.20M | $26.80B |
| Net margin | 72.6% | 28.5% |
| P/E (trailing FY) | 16.0 | 21.4 |
| SEC filings | 1,133 | 984 |
JOHNSON & JOHNSON is 80.4x more valuable than TG THERAPEUTICS, INC. by market capitalization ($574.10 B vs $7.14 B).
In their latest fiscal years, TG THERAPEUTICS, INC. reported $616.29M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: TG THERAPEUTICS, INC. and JOHNSON & JOHNSON, or browse the full rankings.